- Home
- PRSO vs LIPO Comparison
PRSO vs LIPO Comparison
Compare PRSO & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSO
- LIPO
- Stock Information
- Founded
- PRSO 2008
- LIPO 2005
- Country
- PRSO United States
- LIPO United States
- Employees
- PRSO N/A
- LIPO N/A
- Industry
- PRSO Semiconductors
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- PRSO Technology
- LIPO Health Care
- Exchange
- PRSO Nasdaq
- LIPO Nasdaq
- Market Cap
- PRSO 4.5M
- LIPO 3.8M
- IPO Year
- PRSO 2001
- LIPO 2022
- Fundamental
- Price
- PRSO $1.00
- LIPO $2.85
- Analyst Decision
- PRSO Strong Buy
- LIPO Strong Buy
- Analyst Count
- PRSO 2
- LIPO 1
- Target Price
- PRSO $3.38
- LIPO $16.00
- AVG Volume (30 Days)
- PRSO 498.5K
- LIPO 91.5K
- Earning Date
- PRSO 03-17-2025
- LIPO 02-25-2025
- Dividend Yield
- PRSO N/A
- LIPO N/A
- EPS Growth
- PRSO N/A
- LIPO N/A
- EPS
- PRSO N/A
- LIPO N/A
- Revenue
- PRSO $12,728,000.00
- LIPO $483,533.00
- Revenue This Year
- PRSO $9.59
- LIPO N/A
- Revenue Next Year
- PRSO $1.63
- LIPO N/A
- P/E Ratio
- PRSO N/A
- LIPO N/A
- Revenue Growth
- PRSO N/A
- LIPO 0.78
- 52 Week Low
- PRSO $0.73
- LIPO $2.21
- 52 Week High
- PRSO $6.91
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- PRSO 46.41
- LIPO 45.72
- Support Level
- PRSO $0.95
- LIPO $2.78
- Resistance Level
- PRSO $1.50
- LIPO $3.17
- Average True Range (ATR)
- PRSO 0.19
- LIPO 0.29
- MACD
- PRSO -0.02
- LIPO -0.04
- Stochastic Oscillator
- PRSO 9.09
- LIPO 7.61
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.